Guyer William 4
4 · CORCEPT THERAPEUTICS INC · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Guyer William
Chief Development Officer
Transactions
- Award
Common Stock
[F1][F2][F3]2026-03-02$35.97/sh+498$17,913→ 1,733 total - Award
Common Stock
[F4][F3]2026-03-02+498→ 2,231 total
Footnotes (4)
- [F1]The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026.
- [F2]In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
- [F3]Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F4]Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for William Guyer.|2026-03-04